Putative in vivo kinases:
Chk1 T159-p
TAK1 T176-p
Regulatory protein:
FGFR1 Y336-p
Treatment:
anti-CD3 S212-p , S344-p
CXCL12 S259-p
dasatinib S344-p
ephrin_B1 Y336-p
FGF2 Y336-p
ischemia S29-p , S212-p , S324-p
metastatic potential S259-p
MG132_withdrawal S189-p , S259-p , S344-p
nocodazole S149-p , S212-p , S225-p , S259-p , S341-p , S344-p
PI-103 S259-p
vorinostat K22-ac , K168-ac , K173-ac